文献速递糖尿病

肾小管Hnrnpf缺失下调SGLT2减轻糖尿病小鼠超滤和肾损伤

Deletion of heterogeneous nuclear ribonucleoprotein F in renal tubules downregulates SGLT2 expression and attenuates hyperfiltration and kidney injury in a mouse model of diabetes.
PubMed 文献 · Diabetologia · 2021-08-09

该研究在1型糖尿病Akita小鼠中探讨肾小管特异性敲除Hnrnpf对肾小球超滤和肾损伤的影响。雄性非糖尿病对照、Akita及Akita HnrnpfRT KO小鼠观察至24周(每组n=8)。结果显示Akita HnrnpfRT KO小鼠血糖更低、尿糖排泄增加,且肾肥大、肾小球超滤、系膜扩张、足细胞足突融合、肾间质纤维化及白蛋白尿均减轻;SGLT2表达下调,而Agt表达进一步升高。结论认为糖尿病条件下SGLT2下调的肾脏保护作用超过Agt的损伤作用,部分通过激活管球反馈实现。

要点

  • 肾小管Hnrnpf敲除可下调SGLT2表达并减轻糖尿病小鼠肾小球超滤和肾损伤。
  • Akita HnrnpfRT KO小鼠血压较Akita小鼠更高,但血糖更低且尿糖排泄增加。
  • 选择性A1腺苷受体抑制剂可逆转Akita HnrnpfRT KO小鼠的肾小球滤过率降低。

核心结论

  • 糖尿病条件下SGLT2下调的肾脏保护效应超过Agt升高的肾脏损伤效应,至少部分通过激活管球反馈实现。

研究设计与样本

  • 研究通过将肾小管特异性Pax8-Cre小鼠与Akita floxed-Hnrnpf小鼠杂交,在C57BL/6背景上生成Akita HnrnpfRT KO小鼠。
  • 雄性非糖尿病对照、Akita及Akita HnrnpfRT KO小鼠观察至24周龄,每组n=8。

主要发现

  • Akita小鼠收缩压高于对照,Akita HnrnpfRT KO小鼠收缩压显著高于Akita小鼠。
  • 与Akita小鼠相比,Akita HnrnpfRT KO小鼠血糖更低且尿糖排泄增加。
  • Akita小鼠出现肾肥大、肾小球超滤(GFR升高)、肾小球增大、系膜扩张、足细胞足突融合、肾小球基底膜增厚、肾间质纤维化及白蛋白尿增加,这些异常在Akita HnrnpfRT KO小鼠中减轻。
  • 选择性A1腺苷受体抑制剂处理Akita HnrnpfRT KO小鼠后GFR升高。
  • Akita小鼠肾脏Agt表达升高,Akita HnrnpfRT KO小鼠进一步升高;Sglt2表达在Akita小鼠升高,在Akita HnrnpfRT KO小鼠降低。

临床怎么用

  • 在糖尿病肾病中,肾小管SGLT2下调可能通过管球反馈减轻超滤和肾损伤,但需权衡Agt升高带来的潜在风险。

局限性

  • 研究为小鼠模型,结论外推至人类糖尿病肾病需谨慎。
  • 样本量每组n=8,观察至24周,长期效应未评估。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

AIMS/HYPOTHESIS: We previously reported that renal tubule-specific deletion of heterogeneous nuclear ribonucleoprotein F (Hnrnpf) results in upregulation of renal angiotensinogen (Agt) and downregulation of sodium-glucose co-transporter 2 (Sglt2) in HnrnpfRT knockout (KO) mice. Non-diabetic HnrnpfRT KO mice develop hypertension, renal interstitial fibrosis and glycosuria with no renoprotective effect from downregulated Sglt2 expression. Here, we investigated the effect of renal tubular Hnrnpf deletion on hyperfiltration and kidney injury in Akita mice, a model of type 1 diabetes. METHODS: Akita HnrnpfRT KO mice were generated through crossbreeding tubule-specific (Pax8)-Cre mice with Akita floxed-Hnrnpf mice on a C57BL/6 background. Male non-diabetic control (Ctrl), Akita, and Akita HnrnpfRT KO mice were studied up to the age of 24 weeks (n = 8/group). RESULTS: Akita mice exhibited elevated systolic blood pressure as compared with Ctrl mice, which was significantly higher in Akita HnrnpfRT KO mice than Akita mice. Compared with Akita mice, Akita HnrnpfRT KO mice had lower blood glucose levels with increased urinary glucose excretion. Akita mice developed kidney hypertrophy, glomerular hyperfiltration (increased glomerular filtration rate), glomerulomegaly, mesangial expansion, podocyte foot process effacement, thickened glomerular basement membranes, renal interstitial fibrosis and increased albuminuria. These abnormalities were attenuated in Akita HnrnpfRT KO mice. Treatment of Akita HnrnpfRT KO mice with a selective A1 adenosine receptor inhibitor resulted in an increase in glomerular filtration rate. Renal Agt expression was elevated in Akita mice and further increased in Akita HnrnpfRT KO mice. In contrast, Sglt2 expression was increased in Akita and decreased in Akita HnrnpfRT KO mice. CONCLUSIONS/INTERPRETATION: The renoprotective effect of Sglt2 downregulation overcomes the renal injurious effect of Agt when these opposing factors coexist under diabetic conditions, at least partly via the activation of tubuloglomerular feedback.

来源:Diabetologia,查看原文。版权归原作者所有。

引用

  1. Miyata KN, Lo CS, Zhao S, et al. Deletion of heterogeneous nuclear ribonucleoprotein F in renal tubules downregulates SGLT2 expression and attenuates hyperfiltration and kidney injury in a mouse model of diabetes. Diabetologia. 2021. PMID: 34370045. doi:10.1007/s00125-021-05538-9

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。